Preview Mode Links will not work in preview mode

Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.

Oct 25, 2022

"First, do no harm" is a popular saying amongst those involved in the healthcare, medicine, or bioethics field, and is a basic principle taught in health-related courses. To faithfully follow this principle, a health professional should help their patients by recommending tests or treatments for which the potential benefits outweigh the risks of harm.

In this episode, Michael Fronstin, Global Head of Clinical Regulatory & Safety Research and Consulting and Susanne Faber, Director, Advanced Methodologies Clinical Regulatory & Safety, both from Cerner Enviza, share the value and importance of real-world datasets containing de-identified, person-centric, longitudinal records to monitor safety.